Mysoline (Primidone)

Mysoline (Primidone) is an antiepileptic medication that modulates neuronal excitability in seizure‑related pathways.

• Partial seizures: helps reduce the frequency and severity of focal onset seizures.
• Generalized tonic‑clonic seizures: provides control of convulsive episodes across the brain.
• Essential tremor: diminishes tremor amplitude in patients with this movement disorder.

• Primidone is metabolized in the liver to phenobarbital and phenylethylmalonamide, both of which enhance gamma‑aminobutyric acid (GABA)–mediated neuronal inhibition. The increased GABA activity raises the seizure threshold and stabilises neuronal firing, thereby reducing the occurrence of epileptic discharges and tremor activity.

Mysoline may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects

• Drowsiness: feeling unusually sleepy or fatigued.
• Dizziness: light‑headed sensation, especially when standing quickly.
• Nausea: mild stomach upset or queasiness.
• Ataxia: unsteady gait or coordination problems.
• Rash: mild skin irritation or redness.

Serious or Rare Side Effects

• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Blood dyscrasias: agranulocytosis, aplastic anemia, or thrombocytopenia.
• Hepatic dysfunction: jaundice, elevated liver enzymes.
• Respiratory depression: markedly slowed breathing.
• Suicidal thoughts: emergence of depressive or suicidal ideation.

Before initiating Mysoline, clinicians should evaluate patient history and monitor specific parameters.

• Monitor blood counts: perform regular complete blood count tests to detect hematologic abnormalities.
• Assess liver function: check hepatic enzymes periodically, especially in patients with known liver disease.
• Avoid abrupt discontinuation: taper the dose under medical supervision to prevent withdrawal seizures.
• Pregnancy considerations: use only if potential benefit justifies potential risk to the fetus.
• Caution in depression: monitor for mood changes or suicidal thoughts.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Mysoline can affect, and be affected by, several concomitant medications.

Major Interactions (Avoid)

• CYP3A4 inducers (e.g., carbamazepine, phenytoin): may reduce Primidone plasma levels, decreasing efficacy.
• Warfarin: increased anticoagulant effect, raising bleeding risk.
• Oral contraceptives: reduced hormonal efficacy, potentially leading to unintended pregnancy.

Moderate Interactions (Monitor Closely)

• CNS depressants (e.g., benzodiazepines, opioids): additive sedation and respiratory depression.
• Other antiepileptics (e.g., valproate, levetiracetam): may require dose adjustments.
• Alcohol: enhances sedative effects and impairs coordination.